AstraZeneca's Imfinzi + CTLA-4 inhibitor improves survival as liver cancer treatment
19 Januar 2022 - 12:29AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
AstraZeneca (NYSE:AZN)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
AstraZeneca (NYSE:AZN)
Historical Stock Chart
Von Apr 2023 bis Apr 2024